Polymorphism (-499C/G) in DDAH2 promoter may act as a protective factor for metabolic syndrome: A case-control study in Azar-Cohort population.

doi:10.20945/2359-3997000000391

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Polymorphism (-499C/G) in DDAH2 promoter may act as a protective factor for metabolic syndrome: A case-control study in Azar-Cohort population.

Archives of endocrinology and metabolism - 3 Nov 2021

Faramarzi Elnaz, Aftabi Younes, Ansarin Khalil, Somi Mohammad Hossein, Gilani Neda, Seyedrezazadeh Ensiyeh

Abstract excerpt

OBJECTIVE: Globally developing metabolic syndrome (MetS) prevalence as a major health problem can be related to multiple factors of genetic and environmental. Dimethylaminohydrolase 2 (DDAH2) is the main enzyme implicated in the cardiovascular system, which regulates the nitric oxide pathway. This study investigated the association of DDAH2 polymorphism -499C/G (rs805305) with the risk of MetS among the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Metabolic Syndrome

Share to Polymorphism, Genetic

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Share to Protective Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 34283907
DOI: 10.20945/2359-3997000000391
PMCID: PMC10522192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism (-499C/G) in DDAH2 promoter may act as a protective factor for metabolic syndrome: A case-control study in Azar-Cohort population.PMID 34283907Read ↗

Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian patients.Semantic proximity Read ↗

DDAH1 promoter -396 4N insertion variant is associated with increased risk of type 2 diabetes in a gender-dependent manner.Semantic proximity Read ↗

Protective role of DDAH2 (rs805304) gene polymorphism in patients with myocardial infarction.Semantic proximity Read ↗

The association between CYBA gene C242T variant and risk of metabolic syndrome.Semantic proximity Read ↗

Association between variation in the genes DDAH1 and DDAH2 and hypertension among Uygur, Kazakh and Han ethnic groups in China.Semantic proximity Read ↗

The Association Between Serum Uric Acid and the Cardiometabolic Phenotype Among Healthcare Workers in Azar Cohort StudySemantic proximity Read ↗

DDAH gene and cardiovascular risk.Semantic proximity Read ↗

Association of the DDAH2 gene polymorphism with type 2 diabetes and hypertension.Semantic proximity Read ↗

Genotypes of ANKK1 and DRD2 genes and risk of metabolic syndrome and its components: A cross-sectional study on Iranian women.Semantic proximity Read ↗

Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease.Semantic proximity Read ↗

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.Semantic proximity Read ↗

Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.